未登录

L

Laura Marelli

University of London

H指数:26

被引数:4,417

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transforming transnasal endoscopy services: A multicentre service evaluation pilot project

CLINICAL MEDICINE

IF3.9

2025-05-010

OAAI

Can GastroPanel be used as a triage tool to select patients with advanced atrophic gastritis for gastroscopy? A prospective clinical validation study

GastroPanel可以作为分诊工具来选择晚期萎缩性胃炎患者进行胃镜检查吗？前瞻性临床验证研究

BMJ OPEN GASTROENTEROLOGY

IF2.9

2025-01-060

OAAI

GastroPanel: A blood test to triage dyspeptic patients with atrophic gastritis at risk of developing gastric adenocarcinoma

ANNALS OF ONCOLOGY

IF65.4

2023-06-010

OA

CORRELATION BETWEEN CLINICAL RESPONSE AND ANEMIA RESOLUTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF INHIBITORS

DIGESTIVE AND LIVER DISEASE

IF3.8

2016-02-010

PREAI

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

ANNALS OF ONCOLOGY

IF65.4

2013-10-01291

OAAI

Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma

LIVER INTERNATIONAL

IF5.2

2013-03-2651

PREAI

The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis

JOURNAL OF GASTROENTEROLOGY

IF5.5

2012-11-0336

OA

Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: Trans-arterial radio-embolisation of HCC

CANCER TREATMENT REVIEWS

IF10.5

2012-10-0134

PRE

Comparison of Cystatin C and Creatinine-based Glomerular Filtration Rate Formulas with 51Cr-EDTA Clearance in Patients with Cirrhosis

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2011-01-0155

OAAI

Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date

JOURNAL OF HEPATOLOGY

IF33

2010-09-0111

OA

WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS?

JOURNAL OF HEPATOLOGY

IF33

2010-04-011

OAAI

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2009-09-0347

OAAI

Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2009-05-1437

OAAI

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

NEUROENDOCRINOLOGY

IF2.8

2009-03-2362

PREAI

Tumour Size and Differentiation in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation: External Validation of a New Prognostic Score

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2008-09-0653

PREAI

MELD and gender in the waiting list for liver transplantation

TRANSPLANTATION

IF5

2008-05-271

OA

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

LIVER TRANSPLANTATION

IF3.9

2008-02-01122

OA

Transjugular liver biopsy: Not a second rate biopsy

JOURNAL OF HEPATOLOGY

IF33

2008-01-010

PREAI

Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC

CANCER TREATMENT REVIEWS

IF10.5

2007-08-01234

PREAI

Transjugular liver biopsy - Indications, adequacy, quality of specimens, and complications - A systematic review

JOURNAL OF HEPATOLOGY

IF33

2007-08-01270

OA